Inhibitory effect of Mps1 specific siRNA on human cervical cancer HeLaS3 cell proliferation

WANG Wen-jun,LING You-guo,WANG Ying,ZHANG Yan-hong,ZHANG Bu-chang,XU Quan-bin,ZHONG Hui
DOI: https://doi.org/10.7644/j.issn.1674-9960.2013.03.010
2013-01-01
Abstract:Objective To validate the specificity of a small interference RNA(siRNA) for Mps1 in order to pave the way for its application in tumor therapy.Methods A siRNA against the 5′end coding sequence of Mps1(siMps1) was designed and synthesized before the knockdown efficiency of siMps1 was determined by detecting the Mps1 protein level via Western blotting,and by checking tumor growth inhibition and mitotic defects upon Mps1 depletion.A stable cell line SW480-YFPMps1siR/shRNA was generated to find out whether the expression of a siMps1-resistant YFPMps1siR could rescue the defects by the Mps1 depletion with a retrovirus-expressed siMps1.Results The transfection of siMps1 decreased the protein level of Mps1 significantly,causing a reduced mitotic index and chromosomal misalignment.Furthermore,HeLaS3 cells transfected with siMps1 committed extensive cell death,characterized by the increasing percentage of large cells with a multilobed nucleus.The retrovirus-expressed siMps1could also deplete endogenous Mps1 but failed to induce any detectable defects in SW480-YFPMps1siR/shRNA cell line.Conclusion siMps1 can deplete Mps1 with high efficiency and specificity,with potential application in tumor therapy.
What problem does this paper attempt to address?